Background Acute kidney disease (AKD) defines the period after kidney damage and it is a
critical period of both repair and fibrotic pathways. However, the outcomes of patients with …

Previous studies have explored the effects of glucagon-like peptide-1 receptor agonists
(GLP-1 RAs) in reducing cardiovascular events in type 2 diabetes. Here we show that GLP-1 …

Background: The growing complexity of patient data and the intricate relationship between
heart failure (HF) and acute kidney injury (AKI) underscore the potential benefits of …

Background Insulin resistance (IR) can be effectively assessed using the dependable
surrogate biomarker triglyceride-glucose (TyG) index. In various critical care contexts, like …

Background Acute kidney injury (AKI) is common and associated with adverse outcomes as
well as important healthcare costs. However, evidence examining the epidemiology of acute …

Acute heart failure (AHF) is a common and severe condition with a poor prognosis. Its
course is often complicated by worsening renal function (WRF), exacerbating the outcome …

Acute kidney disease (AKD) is a critical transitional period between acute kidney injury and
chronic kidney disease. The incidence of AKD following acute kidney injury is approximately …

Acute kidney injury (AKI) affects a large proportion of hospitalized children and increases
morbidity and mortality in this population. Initially thought to be a self-limiting condition with …

Background The International Society of Nephrology proposes an acute kidney disease
(AKD) management strategy that includes a risk score to aid AKD identification in low-and …

Acute kidney injury (AKI) is associated with persistent renal dysfunction, the receipt of
dialysis, dialysis dependence, and mortality. Accordingly, the concept of major adverse …